nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Decitabine—DNMT1—type 2 diabetes mellitus	0.0112	0.699	CrCbGaD
Emtricitabine—Lamivudine—ABCC2—type 2 diabetes mellitus	0.00324	0.202	CrCbGaD
Emtricitabine—Zalcitabine—CYP3A4—type 2 diabetes mellitus	0.0016	0.0997	CrCbGaD
Emtricitabine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000796	0.000809	CcSEcCtD
Emtricitabine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000794	0.000807	CcSEcCtD
Emtricitabine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000794	0.000807	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000792	0.000805	CcSEcCtD
Emtricitabine—Myalgia—Valsartan—type 2 diabetes mellitus	0.00079	0.000803	CcSEcCtD
Emtricitabine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00079	0.000803	CcSEcCtD
Emtricitabine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000789	0.000801	CcSEcCtD
Emtricitabine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000787	0.0008	CcSEcCtD
Emtricitabine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000787	0.0008	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000784	0.000797	CcSEcCtD
Emtricitabine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000782	0.000794	CcSEcCtD
Emtricitabine—Myalgia—Orlistat—type 2 diabetes mellitus	0.00078	0.000793	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000779	0.000791	CcSEcCtD
Emtricitabine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000778	0.00079	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000775	0.000788	CcSEcCtD
Emtricitabine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000772	0.000785	CcSEcCtD
Emtricitabine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000761	0.000774	CcSEcCtD
Emtricitabine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000759	0.000771	CcSEcCtD
Emtricitabine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000758	0.000771	CcSEcCtD
Emtricitabine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000755	0.000768	CcSEcCtD
Emtricitabine—Infection—Valsartan—type 2 diabetes mellitus	0.000752	0.000764	CcSEcCtD
Emtricitabine—Rash—Glipizide—type 2 diabetes mellitus	0.000752	0.000764	CcSEcCtD
Emtricitabine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000751	0.000763	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000751	0.000763	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00075	0.000763	CcSEcCtD
Emtricitabine—Headache—Glipizide—type 2 diabetes mellitus	0.000747	0.000759	CcSEcCtD
Emtricitabine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000745	0.000757	CcSEcCtD
Emtricitabine—Infection—Orlistat—type 2 diabetes mellitus	0.000743	0.000755	CcSEcCtD
Emtricitabine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000742	0.000755	CcSEcCtD
Emtricitabine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000741	0.000753	CcSEcCtD
Emtricitabine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00074	0.000752	CcSEcCtD
Emtricitabine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000739	0.000751	CcSEcCtD
Emtricitabine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000737	0.000749	CcSEcCtD
Emtricitabine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000736	0.000748	CcSEcCtD
Emtricitabine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000735	0.000747	CcSEcCtD
Emtricitabine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000735	0.000747	CcSEcCtD
Emtricitabine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000734	0.000746	CcSEcCtD
Emtricitabine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000734	0.000746	CcSEcCtD
Emtricitabine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000729	0.000741	CcSEcCtD
Emtricitabine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000728	0.00074	CcSEcCtD
Emtricitabine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000727	0.000739	CcSEcCtD
Emtricitabine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000726	0.000738	CcSEcCtD
Emtricitabine—Back pain—Losartan—type 2 diabetes mellitus	0.000726	0.000738	CcSEcCtD
Emtricitabine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000725	0.000737	CcSEcCtD
Emtricitabine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000725	0.000737	CcSEcCtD
Emtricitabine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00072	0.000732	CcSEcCtD
Emtricitabine—Myalgia—Metformin—type 2 diabetes mellitus	0.000719	0.000731	CcSEcCtD
Emtricitabine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000716	0.000727	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000714	0.000726	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000711	0.000723	CcSEcCtD
Emtricitabine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00071	0.000722	CcSEcCtD
Emtricitabine—Nausea—Glipizide—type 2 diabetes mellitus	0.000708	0.00072	CcSEcCtD
Emtricitabine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000708	0.000719	CcSEcCtD
Emtricitabine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000705	0.000717	CcSEcCtD
Emtricitabine—Pain—Gliclazide—type 2 diabetes mellitus	0.000705	0.000716	CcSEcCtD
Emtricitabine—Rash—Glimepiride—type 2 diabetes mellitus	0.000702	0.000713	CcSEcCtD
Emtricitabine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000701	0.000712	CcSEcCtD
Emtricitabine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000699	0.000711	CcSEcCtD
Emtricitabine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000699	0.00071	CcSEcCtD
Emtricitabine—Headache—Glimepiride—type 2 diabetes mellitus	0.000697	0.000709	CcSEcCtD
Emtricitabine—Cough—Irbesartan—type 2 diabetes mellitus	0.000696	0.000707	CcSEcCtD
Emtricitabine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000695	0.000706	CcSEcCtD
Emtricitabine—Anaemia—Losartan—type 2 diabetes mellitus	0.000693	0.000705	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00069	0.000701	CcSEcCtD
Emtricitabine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000687	0.000698	CcSEcCtD
Emtricitabine—Angioedema—Losartan—type 2 diabetes mellitus	0.000686	0.000697	CcSEcCtD
Emtricitabine—Infection—Metformin—type 2 diabetes mellitus	0.000685	0.000696	CcSEcCtD
Emtricitabine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000685	0.000696	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000682	0.000693	CcSEcCtD
Emtricitabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00068	0.000691	CcSEcCtD
Emtricitabine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000679	0.00069	CcSEcCtD
Emtricitabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000679	0.00069	CcSEcCtD
Emtricitabine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000677	0.000688	CcSEcCtD
Emtricitabine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000676	0.000687	CcSEcCtD
Emtricitabine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000676	0.000687	CcSEcCtD
Emtricitabine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000676	0.000687	CcSEcCtD
Emtricitabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000675	0.000686	CcSEcCtD
Emtricitabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000675	0.000686	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000674	0.000685	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000674	0.000685	CcSEcCtD
Emtricitabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000672	0.000683	CcSEcCtD
Emtricitabine—Skin disorder—Metformin—type 2 diabetes mellitus	0.00067	0.000681	CcSEcCtD
Emtricitabine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000668	0.000678	CcSEcCtD
Emtricitabine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000666	0.000677	CcSEcCtD
Emtricitabine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000666	0.000677	CcSEcCtD
Emtricitabine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000664	0.000675	CcSEcCtD
Emtricitabine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000661	0.000672	CcSEcCtD
Emtricitabine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000659	0.00067	CcSEcCtD
Emtricitabine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000659	0.000669	CcSEcCtD
Emtricitabine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000658	0.000669	CcSEcCtD
Emtricitabine—Cough—Losartan—type 2 diabetes mellitus	0.000655	0.000665	CcSEcCtD
Emtricitabine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000655	0.000665	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000654	0.000664	CcSEcCtD
Emtricitabine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000653	0.000663	CcSEcCtD
Emtricitabine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000651	0.000662	CcSEcCtD
Emtricitabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000651	0.000662	CcSEcCtD
Emtricitabine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000649	0.00066	CcSEcCtD
Emtricitabine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000647	0.000658	CcSEcCtD
Emtricitabine—Infection—Irbesartan—type 2 diabetes mellitus	0.000646	0.000657	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000646	0.000656	CcSEcCtD
Emtricitabine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000645	0.000656	CcSEcCtD
Emtricitabine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000643	0.000654	CcSEcCtD
Emtricitabine—Pain—Orlistat—type 2 diabetes mellitus	0.00064	0.00065	CcSEcCtD
Emtricitabine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000639	0.000649	CcSEcCtD
Emtricitabine—Myalgia—Losartan—type 2 diabetes mellitus	0.000639	0.000649	CcSEcCtD
Emtricitabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000638	0.000649	CcSEcCtD
Emtricitabine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000638	0.000648	CcSEcCtD
Emtricitabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000637	0.000647	CcSEcCtD
Emtricitabine—Anxiety—Losartan—type 2 diabetes mellitus	0.000637	0.000647	CcSEcCtD
Emtricitabine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000633	0.000643	CcSEcCtD
Emtricitabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000632	0.000643	CcSEcCtD
Emtricitabine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000632	0.000642	CcSEcCtD
Emtricitabine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000629	0.000639	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000628	0.000638	CcSEcCtD
Emtricitabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000628	0.000638	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000619	0.000629	CcSEcCtD
Emtricitabine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000619	0.000629	CcSEcCtD
Emtricitabine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000615	0.000625	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000612	0.000622	CcSEcCtD
Emtricitabine—Infection—Losartan—type 2 diabetes mellitus	0.000608	0.000618	CcSEcCtD
Emtricitabine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000607	0.000617	CcSEcCtD
Emtricitabine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000607	0.000617	CcSEcCtD
Emtricitabine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000601	0.000611	CcSEcCtD
Emtricitabine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.0006	0.00061	CcSEcCtD
Emtricitabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.0006	0.000609	CcSEcCtD
Emtricitabine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000599	0.000608	CcSEcCtD
Emtricitabine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000596	0.000606	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000595	0.000605	CcSEcCtD
Emtricitabine—Fatigue—Metformin—type 2 diabetes mellitus	0.000594	0.000604	CcSEcCtD
Emtricitabine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000594	0.000604	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000593	0.000602	CcSEcCtD
Emtricitabine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000591	0.000601	CcSEcCtD
Emtricitabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000591	0.000601	CcSEcCtD
Emtricitabine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000591	0.000601	CcSEcCtD
Emtricitabine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000588	0.000597	CcSEcCtD
Emtricitabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000584	0.000594	CcSEcCtD
Emtricitabine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000584	0.000593	CcSEcCtD
Emtricitabine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000583	0.000593	CcSEcCtD
Emtricitabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00058	0.00059	CcSEcCtD
Emtricitabine—Rash—Glyburide—type 2 diabetes mellitus	0.000579	0.000588	CcSEcCtD
Emtricitabine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000578	0.000588	CcSEcCtD
Emtricitabine—Headache—Glyburide—type 2 diabetes mellitus	0.000575	0.000584	CcSEcCtD
Emtricitabine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000573	0.000582	CcSEcCtD
Emtricitabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000564	0.000573	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000564	0.000573	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000562	0.000571	CcSEcCtD
Emtricitabine—Cough—Ramipril—type 2 diabetes mellitus	0.000561	0.000571	CcSEcCtD
Emtricitabine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000561	0.00057	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000558	0.000567	CcSEcCtD
Emtricitabine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000558	0.000567	CcSEcCtD
Emtricitabine—Pain—Irbesartan—type 2 diabetes mellitus	0.000556	0.000565	CcSEcCtD
Emtricitabine—Insomnia—Losartan—type 2 diabetes mellitus	0.000554	0.000563	CcSEcCtD
Emtricitabine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000551	0.00056	CcSEcCtD
Emtricitabine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00055	0.000559	CcSEcCtD
Emtricitabine—Urticaria—Metformin—type 2 diabetes mellitus	0.000548	0.000557	CcSEcCtD
Emtricitabine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000548	0.000557	CcSEcCtD
Emtricitabine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000548	0.000557	CcSEcCtD
Emtricitabine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000546	0.000555	CcSEcCtD
Emtricitabine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000546	0.000555	CcSEcCtD
Emtricitabine—Nausea—Glyburide—type 2 diabetes mellitus	0.000545	0.000554	CcSEcCtD
Emtricitabine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000545	0.000554	CcSEcCtD
Emtricitabine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000545	0.000554	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000544	0.000553	CcSEcCtD
Emtricitabine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000543	0.000552	CcSEcCtD
Emtricitabine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000539	0.000548	CcSEcCtD
Emtricitabine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000537	0.000546	CcSEcCtD
Emtricitabine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000536	0.000544	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000532	0.000541	CcSEcCtD
Emtricitabine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000529	0.000538	CcSEcCtD
Emtricitabine—Fatigue—Losartan—type 2 diabetes mellitus	0.000528	0.000537	CcSEcCtD
Emtricitabine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000524	0.000533	CcSEcCtD
Emtricitabine—Pain—Losartan—type 2 diabetes mellitus	0.000524	0.000532	CcSEcCtD
Emtricitabine—Rash—Gliclazide—type 2 diabetes mellitus	0.00052	0.000528	CcSEcCtD
Emtricitabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000519	0.000528	CcSEcCtD
Emtricitabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000518	0.000526	CcSEcCtD
Emtricitabine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000517	0.000525	CcSEcCtD
Emtricitabine—Headache—Gliclazide—type 2 diabetes mellitus	0.000516	0.000525	CcSEcCtD
Emtricitabine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000515	0.000523	CcSEcCtD
Emtricitabine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000514	0.000523	CcSEcCtD
Emtricitabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000514	0.000523	CcSEcCtD
Emtricitabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000514	0.000522	CcSEcCtD
Emtricitabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000512	0.00052	CcSEcCtD
Emtricitabine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00051	0.000518	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000501	0.000509	CcSEcCtD
Emtricitabine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000501	0.000509	CcSEcCtD
Emtricitabine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000495	0.000503	CcSEcCtD
Emtricitabine—Asthenia—Metformin—type 2 diabetes mellitus	0.000495	0.000503	CcSEcCtD
Emtricitabine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000489	0.000497	CcSEcCtD
Emtricitabine—Pruritus—Metformin—type 2 diabetes mellitus	0.000488	0.000496	CcSEcCtD
Emtricitabine—Urticaria—Losartan—type 2 diabetes mellitus	0.000486	0.000494	CcSEcCtD
Emtricitabine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000484	0.000492	CcSEcCtD
Emtricitabine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000484	0.000492	CcSEcCtD
Emtricitabine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000481	0.000489	CcSEcCtD
Emtricitabine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000479	0.000487	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000478	0.000486	CcSEcCtD
Emtricitabine—Rash—Valsartan—type 2 diabetes mellitus	0.000477	0.000485	CcSEcCtD
Emtricitabine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000477	0.000485	CcSEcCtD
Emtricitabine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000476	0.000483	CcSEcCtD
Emtricitabine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000475	0.000483	CcSEcCtD
Emtricitabine—Headache—Valsartan—type 2 diabetes mellitus	0.000474	0.000482	CcSEcCtD
Emtricitabine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000472	0.000479	CcSEcCtD
Emtricitabine—Rash—Orlistat—type 2 diabetes mellitus	0.000472	0.000479	CcSEcCtD
Emtricitabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000471	0.000479	CcSEcCtD
Emtricitabine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000471	0.000479	CcSEcCtD
Emtricitabine—Headache—Orlistat—type 2 diabetes mellitus	0.000469	0.000476	CcSEcCtD
Emtricitabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000468	0.000476	CcSEcCtD
Emtricitabine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000467	0.000474	CcSEcCtD
Emtricitabine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000462	0.00047	CcSEcCtD
Emtricitabine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00046	0.000468	CcSEcCtD
Emtricitabine—Dizziness—Metformin—type 2 diabetes mellitus	0.000456	0.000463	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000453	0.000461	CcSEcCtD
Emtricitabine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000453	0.00046	CcSEcCtD
Emtricitabine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000451	0.000458	CcSEcCtD
Emtricitabine—Nausea—Valsartan—type 2 diabetes mellitus	0.00045	0.000457	CcSEcCtD
Emtricitabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000445	0.000452	CcSEcCtD
Emtricitabine—Nausea—Orlistat—type 2 diabetes mellitus	0.000444	0.000452	CcSEcCtD
Emtricitabine—Asthenia—Losartan—type 2 diabetes mellitus	0.000439	0.000446	CcSEcCtD
Emtricitabine—Vomiting—Metformin—type 2 diabetes mellitus	0.000438	0.000446	CcSEcCtD
Emtricitabine—Rash—Metformin—type 2 diabetes mellitus	0.000435	0.000442	CcSEcCtD
Emtricitabine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000434	0.000441	CcSEcCtD
Emtricitabine—Pruritus—Losartan—type 2 diabetes mellitus	0.000433	0.00044	CcSEcCtD
Emtricitabine—Headache—Metformin—type 2 diabetes mellitus	0.000432	0.000439	CcSEcCtD
Emtricitabine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00043	0.000437	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000429	0.000436	CcSEcCtD
Emtricitabine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000419	0.000426	CcSEcCtD
Emtricitabine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000417	0.000424	CcSEcCtD
Emtricitabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000415	0.000422	CcSEcCtD
Emtricitabine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000415	0.000422	CcSEcCtD
Emtricitabine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000414	0.00042	CcSEcCtD
Emtricitabine—Rash—Irbesartan—type 2 diabetes mellitus	0.00041	0.000417	CcSEcCtD
Emtricitabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00041	0.000417	CcSEcCtD
Emtricitabine—Nausea—Metformin—type 2 diabetes mellitus	0.00041	0.000416	CcSEcCtD
Emtricitabine—Headache—Irbesartan—type 2 diabetes mellitus	0.000408	0.000414	CcSEcCtD
Emtricitabine—Dizziness—Losartan—type 2 diabetes mellitus	0.000405	0.000412	CcSEcCtD
Emtricitabine—Vomiting—Losartan—type 2 diabetes mellitus	0.000389	0.000396	CcSEcCtD
Emtricitabine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000387	0.000393	CcSEcCtD
Emtricitabine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000386	0.000393	CcSEcCtD
Emtricitabine—Rash—Losartan—type 2 diabetes mellitus	0.000386	0.000392	CcSEcCtD
Emtricitabine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000386	0.000392	CcSEcCtD
Emtricitabine—Headache—Losartan—type 2 diabetes mellitus	0.000384	0.00039	CcSEcCtD
Emtricitabine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000377	0.000383	CcSEcCtD
Emtricitabine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000371	0.000378	CcSEcCtD
Emtricitabine—Nausea—Losartan—type 2 diabetes mellitus	0.000364	0.00037	CcSEcCtD
Emtricitabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000359	0.000365	CcSEcCtD
Emtricitabine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000347	0.000353	CcSEcCtD
Emtricitabine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000334	0.000339	CcSEcCtD
Emtricitabine—Rash—Ramipril—type 2 diabetes mellitus	0.000331	0.000336	CcSEcCtD
Emtricitabine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000331	0.000336	CcSEcCtD
Emtricitabine—Headache—Ramipril—type 2 diabetes mellitus	0.000329	0.000334	CcSEcCtD
Emtricitabine—Nausea—Ramipril—type 2 diabetes mellitus	0.000312	0.000317	CcSEcCtD
